A 300 Million RMB Medical Cosmetology Cooperation Agreement was reached between Singclean and BD Medical!

Nov. 10, 2023

On November 9th, at the 6th China International Import Expo (CIIE), Singclean Medical successfully signed a strategic cooperation agreement with BD Medical Pharmaceutical Systems. The agreement includes the signing of a 300 million yuan contract for the supply of pre-filled hyaluronic acid injection syringes, aiming to provide a higher quality and safer experience for tens of millions of beauty seekers. In the future, Singclean Medical will work together with BD Medical to promote higher standards for medical cosmetic skin services, jointly create a benchmark for quality medical aesthetics, and introduce more Chinese-made medical beauty products to the global market. Sun Weiqing, General Manager of Hangzhou Singclean Medical, and Jiang Wei, Vice President of Strategic Innovation and Business Excellence for BD Medical in Greater China, attended the signing ceremony.


A 300 Million RMB Medical Cosmetology Cooperation Agreement was reached between Singclean and BD Medical!


300 million yuan contract signed, benefiting tens of millions of beauty seekers.

 

At the CIIE, Singclean Medical signed a strategic cooperation agreement with BD Medical, with a focus on pre-filled syringe products primarily featuring Hylok. This agreement includes a contract worth 3 billion yuan, Singclean Medical expected to provide a higher quality beauty experience to tens of millions of beauty seekers. By applying Hylok glass pre-filled syringe customized by BD Medical for viscous medications, Singclean Medical will offers filler products with significantly higher resistance to pull-out force and torque compared to similar products. With Hylok, Singclean Medical effectively helps prevent the common and challenging issue of leakage when healthcare professionals use pre-filled hyaluronic acid products, making it an ideal solution for hyaluronic acid injections. To solve the problem of needle-syringe disconnection, risking leakage and product contamination.

 

Singclean Medical signed a 3 billion orders with BD Medical at the CIIE


However, BD pre-fillable syringe is only one part of our product quality control process for our hyaluronate gel, from the raw materials, filling, sterilization, labeling to packing, every step for the process is strictly examined by Singclean Medical.

 

Elevated medical aesthetics quality, empowering Chinese manufacturing to go global

 

Medical aesthetics, initially imported into China, has rapidly evolved over the past decade, benefiting from the demographic dividend and economic growth. China's innovations in procedures and clinical achievements now surpass some other countries, with domestic medical aesthetic products meeting international standards in manufacturing processes, technology application, and overall standards, indicating the potential to excel globally.

 

Singclean Medical, a prominent player in China's absorbable biomaterials sector since 2002, has extended its expertise across various fields such as medical, medical aesthetics, skincare, and in vitro diagnostic reagents. With a robust international supply chain and global market presence, the company is committed to continuous innovation and research and development. It has also focused on enhancing its quality management system, earning international acclaim for product quality. Specializing in eight major series of absorbable biomaterials, including hyaluronic acid and collagen, Singclean Medical offers diverse medical innovation solutions to institutions and patients globally, exporting its products to over 80 countries and regions, spanning Europe, South America, the Middle East, and Southeast Asia.

 

Singclean Medical’s cooperation with BD Medical Pharmaceutical Systems in the field of injectable medical products has a long-standing history. Singclean Medical's Singfiller and Singderm cross-linked hyaluronate gel for plastic surgery, and other medical sodium hyaluronate gel used in ophthalmology and orthopedics, have utilized glass pre-filled syringes manufactured by BD Medical. With the outstanding quality of these BD syringes, Singclean Medical’s products has gained widespread recognition in both domestic and international markets.


Singclean Medical signed a 3 billion orders with BD Medical at the CIIE

https://www.singderm.com/singfiller/

 

A 300 Million RMB Medical Cosmetology Cooperation Agreement was reached between Singclean and BD Medical!

https://www.singderm.com/singderm/


Singfiller, a bi-phasic cross-linked sodium hyaluronate gel developed by Singclean Medical, is a sterile, transparent gel of stabilized hyaluronic acid of origin. Singfiller® is supplied in a glass syringe with a luer-lock fitting. The contents of the syringe have been sterilized using moist heat.. Singfiller has gained widespread acceptance across Chinese provinces, boasting a monthly average domestic sales volume surpassing 500,000 units. This product, catering to the needs of millions of medical aesthetics consumers, has secured registrations in various countries, including the European Union, the Middle East, and Southeast Asia. With exports reaching over 30 countries worldwide, Singfiller stands shoulder to shoulder with international brands in both quality and sales performance.

 

Singclean Medical signed a 3 billion orders with BD Medical at the CIIE


Hangzhou Singclean Medical's General Manager, Sun Weiqing, spoked for this cooperation around the quality control, supply chain management, global layout of three directions ,"In recent years, with the introduction of BD's Hylok syringe, a safer and more effective injector product has been brought to a large number of beauty seekers. Consumers now have a higher injection experience, providing more opportunities for our products to go global.

 

The market share of the Chinese medical aesthetics market is less than 5%, but there has been a rapid growth in the demand for medical aesthetics among the general public in recent years, reflecting a trend towards democratization and easy beautification. Products using hyaluronic acid sodium for skin texture improvement, commonly known as water-light products, have officially been classified into the third category of medical products, marking a milestone in the industry.As an upstream enterprise in the field of medical aesthetics, I believe that ensuring quality is the first step for a company to survive in the long term.


 Secondly, with the trend of consumption sinking and democratization, we need to pursue a globalized supply chain, achieve a certain scale, and strive for a balance between quality and cost-effectiveness to achieve greater development. 


Thirdly, globalization. Chinese manufacturing still has advantages globally, and the internationalization of Chinese products is a significant opportunity for our medical aesthetics industry. Therefore, Singclean Medical has always been committed to a globalized path. We have a strong market presence in South America, Europe, Southeast Asia, and the Middle East. "

Hot Products